Clinical trial
Phase 1 Study of SGI-110 in Patients With Acute Myeloid Leukemia
NCT02293993 is registered in ClinicalTrials.gov with Otsuka Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 1 Study of SGI-110 in Patients With Acute Myeloid Leukemia
- Lead sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 7, 2015
- Completion date
- May 31, 2019
- Enrollment
- 21 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
acute myeloid leukemia